TrialThe Journal of infectious diseases2021

A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.

Deborah K McMahon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.